Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)

NCT00332033 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

NIH

Sponsor class

Conditions

Uterine Leiomyoma
Fibroids

Interventions

DRUG: Pirfenidone

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)